2:28 PM
Mar 08, 2018
 |  BC Extra  |  Company News

Management tracks: Takeda, Nimbus

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502) said CFO James Kehoe will step down, effective March 31. He is succeeded by the CFO of Takeda's Europe and Canada business unit, Costa Saroukos.

Nimbus Therapeutics LLC (Cambridge, Mass.) said CSO Rosana Kapeller has resigned. The computational chemistry company is seeking a replacement.

Contract manufacturing company Celltrion Inc. (KOSDAQ:068270) said that Woo-sung Kee is now CEO and vice chairman of Celltrion and Hyoung-ki Kim has transitioned to CEO and vice chairman of the company's global marketing unit, Celltrion Healthcare Co. Ltd. Kim and Kee were dual CEOs of the company.

Bone marrow transplant company Magenta Therapeutics Inc. (Cambridge, Mass.) promoted Christina Isacson to CBO from VP of business development.

Cancer company BioCanCell Ltd. (Tel Aviv:BICL) hired Ronald Knickerbocker as SVP of clinical development and data sciences. He was VP of biomedical data sciences and information at Ariad Pharmaceuticals Inc., which Takeda acquired.

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

Purchase this article for limited one-time distribution and website posting

$750 USD